Andrea Mambrini - Concepedia

Author

Andrea Mambrini

Accademia di Belle Arti di Carrara ORCID

Also Known As

A MAMBRINI, A Mambrini, A. Mambrini, ANDREA MAMBRINI, Andrea Mambrini, Andrea Mambrini MD, Mambrini, Andrea, P. Pacetti, Tommaso Campagnaro

229

Publications

4.4K

Citations

H-Index

Concepts

All Affiliations

Accademia di Belle Arti di Carrara Istituti di Ricovero e Cura a Carattere Scientifico University of Pisa Azienda Usl Toscana Centro Casa Sollievo della Sofferenza

About

Andrea Mambrini is an author at Accademia di Belle Arti di Carrara specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	22	1.6K
2	Gastroenterology	5	5	147
3	Health Sciences	3	3	59
4	Education	1	1	35
5	Cell Biology	1	1	26

Andrea Mambrini

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study. Giammaria Fiorentini, Camillo Aliberti, Massimo Tilli, PubMed	2012	331
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial Chiara Cremolini, Carlotta Antoniotti, Daniele Rossini, The Lancet Oncology OncologyMedicineColorectal CancerPathologyUpfront Folfoxiri	2020	309
Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer Erica J. Childs, Evelina Mocci, Daniele Campa, Nature Genetics Pancreatic CancerMedicinePathologyCancer GenomicsCommon Variation	2015	265
Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21 Mingfeng Zhang, Zhaoming Wang, Ofure Obazee, Oncotarget	2016	110
Maintenance sunitinib or observation in metastatic pancreatic adenocarcinoma: A phase II randomised trial Michele Reni, Stefano Cereda, Michèle Milella, European Journal of Cancer Pancreatic CancerPhase IiGastrointestinal OncologyMetastatic Pancreatic AdenocarcinomaMedicine	2013	90
Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer Emilio Bajetta, Irene Floriani, Maria Di Bartolomeo, Annals of Oncology Surgical OncologyOncologyGastrointestinal OncologyMedicineFolinic Acid	2014	89
Pet therapy effects on oncological day hospital patients undergoing chemotherapy treatment. Massimo Orlandi, Karina Trangeled, Andrea Mambrini, PubMed	2008	85
Combined Irinotecan and Oxaliplatin in Patients with Advanced Pre-Treated Pancreatic Cancer Maurizio Cantore, Carla Rabbi, G. Fiorentini, Oncology	2004	77
<scp><i>TERT</i></scp> gene harbors multiple variants associated with pancreatic cancer susceptibility Daniele Campa, Cosmeri Rizzato, Rachael Z. Stolzenberg‐Solomon, International Journal of Cancer	2015	76
Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5‐fluorouracil in patients with unresectable biliary tract tumors Maurizio Cantore, Andrea Mambrini, Giammaria Fiorentini, Cancer	2005	74

Page 1